Teacher Retirement System of Texas Portfolio holdings
AUM
$23.8B
1-Year Return
25.15%
This Quarter Return
+3.56%
1 Year Return
+25.15%
3 Year Return
+104.39%
5 Year Return
+185.58%
10 Year Return
+422.47%
AUM
$27.7B
AUM Growth
+$6.71B
(+32%)
Cap. Flow
+$6.54B
Cap. Flow
% of AUM
23.57%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
1,710
New
226
Increased
921
Reduced
378
Closed
172
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$399M |
| 3 |
NVIDIA
NVDA
|
+$238M |
| 4 |
Microsoft
MSFT
|
+$224M |
| 5 |
Amazon
AMZN
|
+$175M |
Top Sells
| 1 |
iShares MSCI India ETF
INDA
|
+$252M |
| 2 |
Informatica
INFA
|
+$66.6M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$65M |
| 4 |
Franco-Nevada
FNV
|
+$64.8M |
| 5 |
Target
TGT
|
+$51.6M |
Sector Composition
| 1 | Technology | 26.6% |
| 2 | Financials | 12.62% |
| 3 | Consumer Discretionary | 11.25% |
| 4 | Healthcare | 10.38% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Erasca
ERAS
$448M
| $137K | ﹤0.01% |
54,706
+12,345
| +29% | +$30.9K |
|
1502
Humacyte
HUMA
$233M
| $132K | ﹤0.01% |
26,200
+5,293
| +25% | +$26.7K |
|
1503
PagSeguro Digital
PAGS
$2.81B
| $132K | ﹤0.01% |
21,036
-46,761
| -69% | -$293K |
|
1504
Patterson-UTI
PTEN
$2.15B
| $132K | ﹤0.01% |
+16,029
| New | +$132K |
|
|
KREF
1505
KKR Real Estate Finance Trust
KREF
$644M
| $131K | ﹤0.01% |
12,978
-57,079
| -81% | -$576K |
|
1506
Amcor
AMCR
$18.9B
| $127K | ﹤0.01% |
+13,527
| New | +$127K |
|
1507
MindMed
MNMD
$739M
| $127K | ﹤0.01% |
18,205
+2,915
| +19% | +$20.3K |
|
|
NNDM
1508
Nano Dimension
NNDM
$328M
| $125K | ﹤0.01% |
50,211
+29,082
| +138% | +$72.4K |
|
1509
Immunome
IMNM
$796M
| $124K | ﹤0.01% |
+11,648
| New | +$124K |
|
1510
ARS Pharmaceuticals
SPRY
$1.02B
| $122K | ﹤0.01% |
+11,591
| New | +$122K |
|
1511
Kura Oncology
KURA
$691M
| $120K | ﹤0.01% |
13,749
+2,285
| +20% | +$19.9K |
|
1512
Gores Guggenheim
PSNY
$2.14B
| $115K | ﹤0.01% |
+109,970
| New | +$115K |
|
1513
Riskified
RSKD
$747M
| $115K | ﹤0.01% |
24,346
+14,072
| +137% | +$66.5K |
|
|
VERV
1514
DELISTED
Verve Therapeutics
VERV
| $114K | ﹤0.01% |
20,254
+5,512
| +37% | +$31K |
|
1515
EyePoint Pharmaceuticals
EYPT
$984M
| $113K | ﹤0.01% |
15,192
+2,782
| +22% | +$20.7K |
|
1516
Stoke Therapeutics
STOK
$1.18B
| $113K | ﹤0.01% |
+10,219
| New | +$113K |
|
1517
Inter&Co
INTR
$3.85B
| $109K | ﹤0.01% |
25,754
-77,576
| -75% | -$328K |
|
1518
ImmunityBio
IBRX
$2.38B
| $107K | ﹤0.01% |
41,742
+7,067
| +20% | +$18.1K |
|
1519
Annexon
ANNX
$234M
| $106K | ﹤0.01% |
+20,568
| New | +$106K |
|
1520
Theravance Biopharma
TBPH
$691M
| $103K | ﹤0.01% |
+10,937
| New | +$103K |
|
1521
Capitol Federal Financial
CFFN
$835M
| $99K | ﹤0.01% |
+16,700
| New | +$99K |
|
1522
Regenxbio
RGNX
$487M
| $97K | ﹤0.01% |
12,590
+2,088
| +20% | +$16.1K |
|
1523
Allogene Therapeutics
ALLO
$246M
| $93K | ﹤0.01% |
43,877
+9,839
| +29% | +$20.9K |
|
1524
Astria Therapeutics
ATXS
$419M
| $91K | ﹤0.01% |
+10,125
| New | +$91K |
|
1525
Phathom Pharmaceuticals
PHAT
$899M
| $90K | ﹤0.01% |
+11,065
| New | +$90K |
|